Search research articles
Contact Us
Filters
Showing results (51-60 of 574) with videos related to
Page
of 58
Sort By:
Future Oncology (London, England)
|
March 14, 2025
The value of real-world evidence in supporting targeted therapies for patients with rare oncogenic drivers in mNSCLC
Misako Nagasaka, Upal Basu Roy, Alexandra Berk, et al.
Oncology and Therapy
|
March 15, 2024
Real-World Treatment Patterns and Survival Among Patients with Stage I-III, Non-Squamous, Non-Small Cell Lung Cancer Receiving Surgery as Primary Treatment
Soo Jin Seung, Daniel Moldaver, Shazia Hassan, et al.
Current Medical Research and Opinion
|
August 5, 2016
Association between time to progression and subsequent survival inceritinib-treated patients with advanced ALK-positive non-small-cell lung cancer
Geoffrey Liu, Jie Zhang, Zheng-Yi Zhou, et al.
BMC Proceedings
|
December 19, 2014
Genetic association analysis for common variants in the Genetic Analysis Workshop 18 data: a Dirichlet regression approach
Osvaldo Espin-Garcia, Xiaowei Shen, Xin Qiu, et al.
Molecular Carcinogenesis
|
August 3, 2013
Interaction of polymorphisms in mitotic regulator genes with cigarette smoking and pancreatic cancer risk
Ji-Hyun Jang, Michelle Cotterchio, Ayelet Borgida, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
May 24, 2019
Investigating the Smoking Cessation Informational Needs of Cancer Patients and Informal Caregivers
Meredith Giuliani, Janette Brual, Lawson Eng, et al.
International Journal of Cancer
|
June 10, 2010
Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients
François Meyer, Geoffrey Liu, Pierre Douville, et al.
Future Oncology (London, England)
|
August 23, 2021
Brigatinib vs alectinib in crizotinib-resistant advanced anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALTA-3)
Sanjay Popat, Geoffrey Liu, Shun Lu, et al.
Cancer Medicine
|
June 19, 2021
The effect of prior cancer on non-small cell lung cancer trial eligibility
Michael Herman, Zhihui Liu, Frances A Shepherd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 30, 2024
Progression-Free Survival Gain: A Reliable Primary End Point for Drug Registration That Can Accelerate Patient Access to Urgently Needed Therapies
David J Stewart, Tim Ramsay, Vishal Navani, et al.
Page
of 58
Search research articles
Search
Showing results (51-60 of 574) with videos related to
Sort By:
Page
of 58
Future Oncology (London, England)
|
March 14, 2025
The value of real-world evidence in supporting targeted therapies for patients with rare oncogenic drivers in mNSCLC
Misako Nagasaka, Upal Basu Roy, Alexandra Berk, et al.
Oncology and Therapy
|
March 15, 2024
Real-World Treatment Patterns and Survival Among Patients with Stage I-III, Non-Squamous, Non-Small Cell Lung Cancer Receiving Surgery as Primary Treatment
Soo Jin Seung, Daniel Moldaver, Shazia Hassan, et al.
Current Medical Research and Opinion
|
August 5, 2016
Association between time to progression and subsequent survival inceritinib-treated patients with advanced ALK-positive non-small-cell lung cancer
Geoffrey Liu, Jie Zhang, Zheng-Yi Zhou, et al.
BMC Proceedings
|
December 19, 2014
Genetic association analysis for common variants in the Genetic Analysis Workshop 18 data: a Dirichlet regression approach
Osvaldo Espin-Garcia, Xiaowei Shen, Xin Qiu, et al.
Molecular Carcinogenesis
|
August 3, 2013
Interaction of polymorphisms in mitotic regulator genes with cigarette smoking and pancreatic cancer risk
Ji-Hyun Jang, Michelle Cotterchio, Ayelet Borgida, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
May 24, 2019
Investigating the Smoking Cessation Informational Needs of Cancer Patients and Informal Caregivers
Meredith Giuliani, Janette Brual, Lawson Eng, et al.
International Journal of Cancer
|
June 10, 2010
Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients
François Meyer, Geoffrey Liu, Pierre Douville, et al.
Future Oncology (London, England)
|
August 23, 2021
Brigatinib vs alectinib in crizotinib-resistant advanced anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALTA-3)
Sanjay Popat, Geoffrey Liu, Shun Lu, et al.
Cancer Medicine
|
June 19, 2021
The effect of prior cancer on non-small cell lung cancer trial eligibility
Michael Herman, Zhihui Liu, Frances A Shepherd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 30, 2024
Progression-Free Survival Gain: A Reliable Primary End Point for Drug Registration That Can Accelerate Patient Access to Urgently Needed Therapies
David J Stewart, Tim Ramsay, Vishal Navani, et al.
Page
of 58